Logo

EPA Hires BioFocus DPI for ToxCast Project; Deal Could Be Worth $8.6M

Apr 19, 2007
NEW YORK (GenomeWeb News) — The US Environmental Protection Agency has hired BioFocus DPI to procure chemicals and manage compounds for the agency’s ToxCast program, BioFocus parent company Galapagos said yesterday. 
 
Galapagos said the contract has a total value of as much as €6.3 million ($8.6 million) over up to five years.
 
Under the agreement, BioFocus will “acquire, analyze, store, format and deliver specific compounds” to the EPA at various sites,” the company said.
 
The EPA’s ToxCast program aims to predict toxicity and analyze 200 or more chemicals using genomic analysis, high-throughput screening assays, and cell-based phenotypic assays.   

Breaking News
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.